Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|August 15, 2015
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-AnalysisMiguel A Ortiz, Concepción Núñez, David Ordóñez, et al.
Human Mutation|March 21, 2020
Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genesElia Gil-Varea, Nino Spataro, Luisa María Villar, et al.
Frontiers in Immunology|February 3, 2022
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the <i>ANKRD55</i>-<i>IL6ST</i> Gene Region in Immature Dendritic CellsJorge Mena, Iraide Alloza, Raquel Tulloch Navarro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II allelesBelén de la Hera, Elena Urcelay, David Brassat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
European Journal of Neurology|July 16, 2025
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis PatientsAndreu Vilaseca, Elena Urcelay, Sunny Malhotra, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2015
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-βMarta F Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.
Journal of Neuroinflammation|September 16, 2018
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease courseElia Gil-Varea, Elena Urcelay, Carles Vilariño-Güell, et al.
Pageof 4